Detailed Product Description 5-Amino-1-Methylquinolinium (5-Amino-1MQ) is a first-in-class, selective NNMT inhibitor designed for research into metabolic regulation, obesity, diabetes, nonalcoholic fatty liver disease, and age-associated muscle degeneration
Symptoms include numbness or tingling in hands and feet, weakness, fatigue, and trouble walking
These findings establish the mechanistic basis for the compound and provide proof of concept for its metabolic effects
From the ASV table (Supplementary Table S1), sums of ASVs within each respective phylum or genus for each sample were calculated to establish the abundance of each phylum or genus per sample
Arrae Health Is Proud To Partner With Oasis Psychiatry & Wellness to offer expanded psychiatry services for our patients and community.
Alternatively, 100mcg can be administered daily for 1 week, followed by every other day for 2 weeks